Consumer Defensive Short holds up to 8 consumer defensive names above $200M short. Selection weighs the model's positive score against its negative score. Returns are those of a short position in the basket, so the figure rises when the basket falls.
Strategy
Equal capital goes into every position. The book is rebuilt each morning from the names the model expects to fall, and the orders are placed as market orders, so shorts and covers fill at the opening price. Positions are held for 6 to 21 days: they are not rotated out before day 6 and are covered by day 21. Every position carries a 40% stop on both sides. A short is covered if the price runs 40% above its entry, and equally if it falls 40% below it, filling at the first open after the level is touched. Reported returns are those of a short position in the basket: the position gains when the basket falls and loses when it rises. They are measured from those opening prices and include every stop exit. A short position's loss is not capped, and borrowing costs and stock-loan fees are not included.
KinderCare releases Q3 2026 results after the close on 2026-11-12 with a 5:00 pm ET call. Consensus is roughly breakeven to a small loss (~-$0.01 to -$0.08 EPS) on revenue near $666-669M versus a $0.13 profit a year ago; the key swing factor is whether management reaffirms its lowered FY2026 guidance (adj. EPS 5-15 cents, revenue $2.66-2.70B) and shows continued narrowing of same-center occupancy declines. A reaffirmation with occupancy improvement could relieve heavy pessimism; another cut would likely extend the selloff.
Rosenblatt lowered its price target on LINC to $40 from $50 while maintaining a Buy rating, citing valuation. The firm acknowledged the 14% Q3 student start rebound and revenue/EPS beat, reinforcing that Q2's soft starts were a one-time event. The PT cut signals tempered near-term upside expectations despite the positive fundamental read.
Class action lead-plaintiff deadline passed Nov 10
Multiple law firms publicized a securities class action covering investors who bought LINC shares between May 11 and August 9, 2026, alleging the company failed to disclose problems converting admissions into student starts. The lead-plaintiff deadline was November 10, 2026. The litigation adds a credibility and legal overhang, though the notices largely repeat the same case and no findings have been made.
LINC reported Q3 2026 adjusted EPS of $0.15 vs. $0.13 consensus and revenue of $159.2M vs. $152.5M expected, with student starts up 14.2% and adjusted EBITDA up 30.8%. Management raised full-year 2026 revenue guidance to $600-605M from $590-600M and narrowed student start growth to 10-12%. The beat and guidance raise, which reversed fears from the Q2 start shortfall, drove a sharp positive reaction (shares up ~24% Monday and ~5.7% Tuesday).
The Board approved a $30M increase to the existing share repurchase authorization, bringing the total to $70M with more than $37M remaining available, after repurchasing 871,135 shares for ~$21.0M in Q3. The expanded buyback and a credit facility amendment enhancing repurchase flexibility provide a supportive demand backstop for the stock near term.
Mike Nuzzo resigned from the Board effective 2026-09-28 citing other time commitments; David Barse (joined Aug 3) replaces him as Head of the Audit Committee and Partners Group's Preston Grasty rejoined effective 2026-09-29. Governance changes at a 69%-Partners-Group-owned company are low-impact near term but worth monitoring for any signal on strategic direction or deleveraging priorities.
S&P cuts KinderCare outlook to negative on enrollment
S&P Global Ratings revised its outlook to negative from stable while affirming the 'B+' issuer credit rating, expecting adjusted leverage to rise above its 5.0x downgrade trigger this year as enrollment pressures weigh on free cash flow and occupancy falls toward ~65% by year-end. The negative outlook raises the risk of an actual downgrade if trends persist, adding balance-sheet overhang to a stock trading near $2 and reinforcing deleveraging as a management priority.
Footprint-optimization plan to close 80-85 centers
Three months ago management cut every major full-year target and formalized closing 80-85 underperforming centers (vs. a historical ~20/year), with 49 closed in Q2 and ~30 more planned in H2, plus ~36 lease exits costing $20-25M. Shares have fallen ~42% since that report; the Q3 print will be judged on execution pace, occupancy benefit (~150 bps eventual), and whether free cash flow (guided under $10M) and leverage (above 3x) deteriorate further.